Although metabolic dysfunction-associated fatty liver disease was more frequent among participants with gallbladder polyps in crude unadjusted comparisons, the liver condition showed no independent association with gallbladder polyps after multivariable adjustment. Researchers evaluated health promotion center data to explore factors associated with gallbladder polyps among patients with metabolic dysfunction-associated fatty liver disease and its different subgroups.
The cross-sectional observational study enrolled a total of 51,420 participants who underwent abdominal ultrasound examinations. Based on ultrasound imaging, participants were categorized into an unaffected control group and a gallbladder polyp group, with polyps detected in 9,341 individuals, representing an overall prevalence of 18.17 percent. Patients diagnosed with metabolic dysfunction-associated fatty liver disease were further classified into distinct clinical subgroups in accordance with consensus criteria.
Multivariable logistic regression models were applied to identify factors associated with gallbladder polyps across the complete study cohort and within each specific subgroup. In multivariable-adjusted analyses among participants with metabolic dysfunction-associated fatty liver disease, male gender demonstrated a statistically significant association with gallbladder polyps, yielding an adjusted odds ratio of 1.743 with a 95 percent confidence interval of 1.605 to 1.893. Smoking status also maintained a statistically significant association, showing an adjusted odds ratio of 1.069 with a 95 percent confidence interval of 1.014 to 1.127.
Within the broader metabolic fatty liver group, diastolic blood pressure and serum 25-hydroxyvitamin D also achieved adjusted statistical significance, with diastolic blood pressure recording an odds ratio of 1.004 and a 95 percent confidence interval of 1.002 to 1.006, and 25-hydroxyvitamin D registering an odds ratio of 1.005 with a 95 percent confidence interval of 1.002 to 1.009. The researchers highlighted that because these odds ratios were exceedingly close to 1.0, the associations were likely a mathematical reflection of the substantial sample size rather than indicators of clinical relevance.
Subgroup analyses demonstrated that factors associated with gallbladder polyps differed according to patient metabolic status. In the subgroup comprising patients with both metabolic dysfunction-associated fatty liver disease and type 2 diabetes, male gender was the factor showing an adjusted statistical association, with an odds ratio of 2.433 and a 95 percent confidence interval of 1.478 to 4.003. In the overweight or obese subgroup, male gender showed an adjusted odds ratio of 1.834 with a 95 percent confidence interval of 1.604 to 2.098, while smoking yielded an adjusted odds ratio of 1.142 with a 95 percent confidence interval of 1.065 to 1.224.
Among participants in the lean metabolic fatty liver subgroup, male gender yielded an adjusted odds ratio of 1.875 with a 95 percent confidence interval of 1.345 to 2.615, and elevated diastolic blood pressure yielded an adjusted odds ratio of 1.019 with a 95 percent confidence interval of 1.007 to 1.031, representing a small effect size. Body mass index showed no association with gallbladder polyps in the general health-check population or the overall metabolic fatty liver cohort, though a weak statistically significant association was observed specifically in the overweight or obese subgroup, demonstrating that risk factor profiles vary across patient categories.
Subject of Research: Factors associated with gallbladder polyps among adults with metabolic dysfunction-associated fatty liver disease
Article Title: Factors associated with gallbladder polyps among adults with metabolic dysfunction-associated fatty liver disease: a cross-sectional study with subgroup analyses
Article References: Chao, G., Chen, C., & Mai, T. (2026). Factors associated with gallbladder polyps among adults with metabolic dysfunction-associated fatty liver disease: a cross-sectional study with subgroup analyses. Frontiers in Endocrinology, 17, Article 1939597. https://doi.org/10.3389/fendo.2026.1939597
Image Credits: AI Generated
DOI: 10.3389/fendo.2026.1939597
Keywords: gallbladder polyps, metabolic dysfunction-associated fatty liver disease, MAFLD, fatty liver disease, ultrasound, cross-sectional study, multivariable logistic regression, type 2 diabetes, overweight MAFLD, obese MAFLD, lean MAFLD, body mass index, smoking, diastolic blood pressure, 25-hydroxyvitamin D, health promotion center, subgroup analysis
News Source: Ophelia Keating. (November 14, 2026). Study Finds Fatty Liver Disease Not Independently Linked to Gallbladder Polyps. Scienmag.



